{"productName":"Foundayo™","molecule":" (orforglipron)","productLogoUrl":"","warning":true,"warnings":[{"title":"WARNING: RISK OF THYROID C-CELL TUMOR","warning":"• In products with glucagon-like peptide-1 (GLP-1) receptor agonist activity that are pharmacologically active in rats and mice, rodent thyroid C-cell tumors (adenomas and carcinomas) have been observed at clinically relevant exposures and are considered GLP-1 receptor-dependent effects in rodents. Orforglipron is not pharmacologically active in rats or mice and did not produce tumors in rodents. While orforglipron is pharmacologically active at the human GLP-1 receptor, the human relevance of GLP-1 receptor-dependent thyroid C-cell tumors observed in rodents has not been determined.\n\n• Foundayo™ (orforglipron) is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors."}],"user":"HCP","extLinks":"http://www.goodrx.com/,http://www.lowestmed.com/,http://www.rxpricequotes.com/,https://www.tsa.gov/","bubbleBackground":"#F2F2F2","bubbleBorderColor":"#F2f2f2","bubbleFromUserBackground":"#D52B1E","bubbleFromUserBorderColor":"#D52B1E","bubbleFromUserTextColor":"White","bubbleTextColor":"Black","botAvatarBackgroundColor":"#FFFFFF","sessionTimeout":1800,"headerBackgroundColor":"#D52B1E","suggestedButtonsBorder":"2px solid #D52B1E","suggestedButtonBackgroundColor":"#D52B1E","suggestedButtonDefaultBackgroundColor":"","interstitialContinueBackground":"#D52B1E","interstitialContinueBorder":"#D52B1E","interstitialExternalLinkMessage":"","botToken":"eyJhbGciOiJSUzI1NiIsImtpZCI6InZfemllcUtLbU9ZZTB4aEt6bW5GWC1CUndrQSIsIng1dCI6InZfemllcUtLbU9ZZTB4aEt6bW5GWC1CUndrQSIsInR5cCI6IkpXVCJ9.eyJib3QiOiJkZXYtbG0tY2hhdGJvdC1ib3QiLCJzaXRlIjoiVnVjeVltc3VvR2ciLCJjb252IjoiQ0YyT3VLRzVkbG03WHpmMWx0OE80NC11cyIsInVzZXIiOiJkbF9mb3VuZGF5b19oY3BfMjc5ODkwYjgtOTBhNC00YWEwLThjNWQtODg1YzAwNDU0NWM0IiwianRpIjoiOERGMkUwMzM1ODNDRjgwLTg0ZDE5YjA4YjJlOTRiMDFhMTU5NmU1OTA1NTJmNTllIiwic2tpIjoiMSIsIm9hdCI6IjE3OTI0Mjk1NDIiLCJuYmYiOjE3OTI0Mjk1NDIsImV4cCI6MTc5MjQzMzE0MiwiaXNzIjoiaHR0cHM6Ly9kaXJlY3RsaW5lLmJvdGZyYW1ld29yay5jb20vIiwiYXVkIjoiaHR0cHM6Ly9kaXJlY3RsaW5lLmJvdGZyYW1ld29yay5jb20vIn0.pfh3fUFZESmmppGCTgNIGN75qBHU3aPbH8KyKUBFIVDsSBg_3XhyDYEfVQEluJwHicH0DB6qP_PEhjNRiNyGu3FNzQlY4y4qx5X3fMJtc2B-cfBwwtJyAiazDwyMubCHHToKwRMTDTBlyitFXp9CK1oYeJtUaod9C2Ilzk7DmAKKGTqDUVtQBqTSErvwWQaaV-5d9TDEOaksc0vnZ2uCCXf57KLwntviqYfNlpTbrIdvvj5046OZrjx8OAJXAg1btANaln2qT8K15pzz2mSDXaeh9lACwULYkiNKbj87e2saTP2cmf0HdhPK6bYL-puDnyablc8Rz5Y_KMHsCjjHtg","userId":"dl_foundayo_hcp_279890b8-90a4-4aa0-8c5d-885c004545c4","verticalAlignment":true,"bannerColor":"#D52B1E","secureLinks":"","apiURL":"https://dev.api.assist.lilly.com","headerTextColor":"","headerHeight":"","responseFeedbackText":"Was this content helpful?","logoHeight":"","enableFeedbackThankYou":false,"thumbsUpThankYou":false,"thumbsUpThankYouText":"","starRatingPromptText":"","starRatingThankYouText":"","starRatingLowScoreText":"","starRatingLowScoreFeedbackButtons":[],"starRatingLowScoreFeedbackThankYouText":"","informationPromptText":"","lillyAssistIcon":"","PersistentChatEnabled":false,"idleTimerEnabled":false,"idleTimeoutSeconds":600,"inputBoxStayFocused":false,"genesysDeploymentId":"","genesysEnvironment":"","trackingId":"8481299a-3876-4669-b946-b3cf62232b50"}